DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Copegus (Ribavirin) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (68)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Copegus (Ribavirin) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 68   Next >>

Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: male

Reactions: Vomiting, Pneumonia, Swelling Face, Haemorrhage, Anaemia, Bone Swelling, Ill-Defined Disorder, Platelet Count Decreased, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-05-23

Copegus
    Indication: Hepatitis C
    Start date: 2012-05-23

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-05-23



Possible Copegus side effects in

Reported by a physician from Brazil on 2012-08-21

Patient:

Reactions: Migraine, Pneumonia, Anaemia, Hyponatraemia, Cystitis, Oesophageal Varices Haemorrhage, Syncope, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C

Copegus
    Dosage: for 24 weeks
    Administration route: Oral
    Indication: Hepatitis C



Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Type 2 Diabetes Mellitus, Pneumonia, Pancreatitis, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Other drugs received by patient: Fosamax; Gabapentin; Acyclovir; Lidex



Possible Copegus side effects in male

Reported by a physician from United States on 2012-08-13

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Pneumonia, Pancreatitis, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Other drugs received by patient: Lidex; Fosamax; Acyclovir; Gabapentin



Possible Copegus side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Weight Decreased, Tinnitus, Chapped Lips, Oropharyngeal Pain, Fatigue, RED Blood Cell Count Decreased, Sinusitis, Back Pain, White Blood Cell Count Decreased, Pneumonia, Dysphagia, Stomatitis, Middle Ear Effusion, Anaemia, Pancytopenia, Rash, LIP Ulceration, Sensory Disturbance, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys

Victrelis
    Dosage: 4 df, tid

Copegus

Other drugs received by patient: Ativan; Accolate; Lexapro; Proair (Albuterol Sulfate); Fluticasone Propionate; Procardia XL



Possible Copegus side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Renal Failure, Pneumonia, Chills, NO Therapeutic Response, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Product Used FOR Unknown Indication

Victrelis

Pegasys

Other drugs received by patient: Insulin; Risperidone; Ativan; Lisinopril; Fenofibrate



Possible Copegus side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: male

Reactions: Fatigue, Dizziness, Blood Sodium Decreased, Decreased Appetite, Cough, White Blood Cell Count Decreased, Pneumonia, Dyspnoea, Haemoptysis, Nausea, Tuberculosis, Haemoglobin Decreased, Diarrhoea, Arthralgia, Sputum Discoloured, Asthenia, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16

Pegasys
    Indication: Hepatitis C
    Start date: 2012-03-16

Other drugs received by patient: Lisinopril



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-25

Patient: female

Reactions: Night Sweats, Pruritus, Pneumonia, Ascites, Loss of Consciousness, RED Blood Cell Count Decreased, Insomnia, Platelet Count Decreased, Blood Pressure Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-01

Copegus
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-01

Boceprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-01



Possible Copegus side effects in male

Reported by a physician from United States on 2012-07-13

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Pneumonia, Hyperbilirubinaemia, Rash, Haemoglobin Decreased, Herpes Simplex Ophthalmic, Pancreatitis, Neutropenia, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Blinded Alisporivir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Other drugs received by patient: Fosamax; Gabapentin; Lidex; Acyclovir



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-07-10

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Dyspnoea, Vomiting, Pneumonia, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Other drugs received by patient: Raltegravir; Citalopram Hydrobromide; Fortijuice; Acetaminophen; Metronidazole; Ciprofloxacin; Fortisip; SUN Bath Protective Tanning Lotion; Acyclovir; Truvada; Nystatin; Citalopram Hydrobromide



Possible Copegus side effects in 53 year old male

Reported by a physician from Germany on 2012-07-05

Patient: 53 year old male

Reactions: Procalcitonin Increased, Pneumonia, Alanine Aminotransferase Increased, Febrile Neutropenia, Cerebral Atrophy, Toxicity To Various Agents, Gamma-Glutamyltransferase Increased, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Mean Cell Haemoglobin Increased, Bone Marrow Failure, Cerebral Microangiopathy, Staphylococcal Bacteraemia, Bone Marrow Toxicity, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Victrelis (Shc-503034)
    Dosage: 800 mg, tid, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-20
    End date: 2012-04-12

Copegus
    Dosage: 800 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-23
    End date: 2012-04-12

Pegasys
    Dosage: 180 mcg;qw; sc
    Indication: Hepatitis C
    Start date: 2012-01-23
    End date: 2012-04-12

Other drugs received by patient: Polamidon; Rekawan; Omeprazole; Dekristol; Sumatriptan



Possible Copegus side effects in female

Reported by a physician from Germany on 2012-07-02

Patient: female, weighing 79.0 kg (173.8 pounds)

Reactions: Pneumonia, Respiratory Failure, Urinary Tract Infection, Cardiovascular Insufficiency, Acute Hepatic Failure, Endocarditis, Lactic Acidosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-05-18

Copegus
    Indication: Hepatitis C
    Start date: 2012-01-01

Boceprevir
    Indication: Hepatitis C
    Start date: 2012-02-01



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-15

Patient: female

Reactions: Pneumonia, Haemorrhage, Anaemia, Atrial Fibrillation

Drug(s) suspected as cause:
Copegus
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-06-15

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Pneumonia, Dyspnoea, Vomiting, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Other drugs received by patient: Truvada; Raltegravir; Acetaminophen; Citalopram Hydrobromide; Metronidazole; Fortijuice; Acyclovir; Ciproflaxacin; Citalopram Hydrobromide; SUN Bath Protective Tanning Lotion; Nystatin; Fortisip



Possible Copegus side effects in male

Reported by a physician from United States on 2012-06-13

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Pneumonia, Pancreatitis, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Alisporivir
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Other drugs received by patient: Gabapentin; Fosamax; Lidex; Acyclovir



Possible Copegus side effects in male

Reported by a physician from United Kingdom on 2012-06-12

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: White Blood Cell Analysis, Vomiting, Pneumonia, Dyspnoea, Pulmonary Tuberculosis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Diarrhoea, Sarcoidosis, Lymphoma, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
    Indication: HIV Infection

BI 201335 (Hcv Protease Inhibitor)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-14

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-03-07

Copegus
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Pegasys
    Indication: HIV Infection
    Start date: 2012-03-13
    End date: 2012-03-14

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11

Other drugs received by patient: Acetaminophen; Citalopram; Truvada; Nystatin; Citalopram; Metronidazole; Raltegravir; Acyclovir; Ciprofloxacin; Fortisip



Possible Copegus side effects in female

Reported by a physician from United States on 2012-06-08

Patient: female

Reactions: Weight Decreased, Tinnitus, Chapped Lips, Oropharyngeal Pain, Fatigue, RED Blood Cell Count Decreased, Sinusitis, White Blood Cell Count Decreased, Back Pain, Pneumonia, Dysphagia, Stomatitis, Middle Ear Effusion, Anaemia, Pancytopenia, Rash, LIP Ulceration, Sensory Disturbance, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-29

Copegus
    Dosage: divided doses
    Indication: Hepatitis C
    Start date: 2011-08-29

Boceprevir
    Dosage: 4 tablets thrice in day.
    Indication: Hepatitis C
    Start date: 2011-09-27

Other drugs received by patient: Advair Diskus 100 / 50; Proair HFA; Ativan; Procardia XL; Accolate; Lexapro



Possible Copegus side effects in male

Reported by a physician from United States on 2012-06-08

Patient: male, weighing 81.7 kg (179.8 pounds)

Reactions: Pneumonia, Renal Failure, NO Therapeutic Response, Chills, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Boceprevir
    Indication: Hepatitis C
    Start date: 2011-09-30
    End date: 2012-01-30

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-01
    End date: 2012-01-05

Copegus
    Indication: Hepatitis C
    Start date: 2011-09-30
    End date: 2012-01-30

Copegus
    End date: 2012-01-30

Other drugs received by patient: Lisinopril; Ativan; Risperidone; Insulin; Fenofibrate



Possible Copegus side effects in male

Reported by a physician from Germany on 2012-06-08

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Pneumonia, Bronchopneumonia, Nausea, Dehydration, General Physical Health Deterioration, Pyrexia, Cystitis, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-20
    End date: 2012-03-12

Pegasys
    Indication: Hepatitis C
    Start date: 2011-12-20

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-20



Possible Copegus side effects in female

Reported by a physician from United States on 2012-06-08

Patient: female

Reactions: Pneumonia, Hypotension, Anaemia, Hypoxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 mcg 1 in i week
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-24

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-24

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-24

Other drugs received by patient: Paxil; Hydrocodone; Vitamin B-12; Fish OIL; Morphine Sulfate; Multi-Vitamin; Trazodone HCL; Xanax



Possible Copegus side effects in female

Reported by a consumer/non-health professional from Colombia on 2012-06-07

Patient: female

Reactions: Pneumonia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-04-01

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Copegus side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-07

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-27

Copegus
    Start date: 2011-07-05
    End date: 2011-07-05

Copegus
    Administration route: Oral
    Start date: 2011-04-27
    End date: 2011-05-10

RO 5466731 (Hcv Ns5b Inhibitor)
    Dosage: date of dicontinuation: 05/jul/2011
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-07-05

Pegasys
    Start date: 2011-04-20
    End date: 2011-06-29

Pegasys
    Start date: 2011-06-29

Copegus
    Start date: 2011-07-05

Pegasys
    Indication: Hepatitis C
    Start date: 2011-03-16
    End date: 2011-04-20

Pegasys
    Start date: 2011-06-29
    End date: 2011-06-29

Copegus
    Administration route: Oral
    Start date: 2011-05-10
    End date: 2011-07-05

Other drugs received by patient: Spironolactone; Lasix; RED Cells Pack; Lortab; Lasix; Rabeprazole Sodium; Alprazolam; Diphenhydramine HCL; Protonix; Lithium Carbonate; Promethazine; Zolpidem; Epoetin Alfa; Acetaminophen



Possible Copegus side effects in female

Reported by a consumer/non-health professional from Colombia on 2012-05-28

Patient: female

Reactions: Pneumonia, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-04-01

Pegasys
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-28

Patient: female, weighing 64.0 kg (140.8 pounds)

Reactions: White Blood Cell Count Decreased, Weight Decreased, Pneumonia, Nausea, Anaemia, Haematemesis, Alopecia, Mood Swings, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-05-18
    End date: 2011-11-17

Copegus
    Indication: Hepatitis C
    Start date: 2011-05-18
    End date: 2011-11-17

Other drugs received by patient: Ondansetron; Wellbutrin; Wellbutrin



Possible Copegus side effects in male

Reported by a physician from United States on 2012-05-25

Patient: male, weighing 81.7 kg (179.8 pounds)

Reactions: Renal Failure, Pneumonia, Chills, NO Therapeutic Response, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Boceprevir
    Indication: Hepatitis C
    Start date: 2011-09-30
    End date: 2012-01-30

Copegus
    End date: 2012-01-30

Copegus
    Indication: Hepatitis C
    Start date: 2011-09-30
    End date: 2012-01-30

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-01
    End date: 2012-01-05

Other drugs received by patient: Insulin; Lisinopril; Ativan; Fenofibrate; Risperidone



Possible Copegus side effects in female

Reported by a physician from United States on 2012-05-25

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Pneumonia, Chronic Obstructive Pulmonary Disease, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-07

Blinded Alisporivir
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-07

Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-04

Other drugs received by patient: Phenergan; Lisinopril; Celexa



Possible Copegus side effects in male

Reported by a physician from United States on 2012-05-24

Patient: male, weighing 75.3 kg (165.6 pounds)

Reactions: Pneumonia, Pancreatitis, Diabetic Ketoacidosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Copegus
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Blinded Alisporivir
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-25

Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20
    End date: 2012-03-15

Other drugs received by patient: Lidex; Acyclovir; Gabapentin; Fosamax



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: female

Reactions: Weight Decreased, Tinnitus, Chapped Lips, Oropharyngeal Pain, Fatigue, RED Blood Cell Count Decreased, Sinusitis, White Blood Cell Count Decreased, Back Pain, Dysphagia, Pneumonia, Stomatitis, Middle Ear Effusion, Anaemia, Pancytopenia, Rash, LIP Ulceration, Sensory Disturbance, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-29

Boceprevir
    Dosage: 4 tablets thrice in day.
    Indication: Hepatitis C
    Start date: 2011-09-27

Copegus
    Dosage: divided doses
    Indication: Hepatitis C
    Start date: 2011-08-29

Other drugs received by patient: Procardia XL; Ativan; Accolate; Proair HFA; Advair Diskus 100 / 50; Lexapro



Possible Copegus side effects in female

Reported by a physician from United States on 2012-05-18

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Pneumonia, Chronic Obstructive Pulmonary Disease, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Alisporivir
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-07

Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-04

Copegus
    Indication: Hepatitis C
    Start date: 2011-08-25
    End date: 2011-11-07

Other drugs received by patient: Lisinopril; Phenergan; Celexa



Possible Copegus side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-10

Patient: female

Reactions: Vomiting, Pneumonia, Pain, Anaemia, Nervous System Disorder, Asthenia, Ill-Defined Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-10-20

Telaprevir
    Indication: Hepatitis C
    Start date: 2011-10-20

Copegus
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-20



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017